MNKD FY 2018 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M+137.2% YoY

Gross Profit

$7M26.5% margin

Operating Income

-$77M-274.9% margin

Net Income

-$87M-312.2% margin

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$108M

Total Liabilities

$283M

Stockholders' Equity

-$175M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$12M	+137.2%
Gross Profit	$7M	-$5M	+234.6%
Operating Income	-$77M	-$108M	+29.2%
Net Income	-$87M	-$117M	+25.9%